Login Register Cart 0
Generic placeholder image

Recent Advances in Food, Nutrition & Agriculture

Editor-in-Chief

ISSN (Print): 2772-574X
ISSN (Online): 2772-5758

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Research Article

Influence of Vitamin D Level on Inflammatory and Prognostic Markers in COVID-19 - A Retrospective Study

Author(s): Sunil Kumar Singh, Shruti Singh*, Rajesh Kumar, Proteesh Rana, Ajay Sharma, Ritu Karwasra, Prashant Kesharwani* and Amirhossein Sahebkar*

Volume 14, Issue 3, 2023

Published on: 09 October, 2023

Page: [190 - 196] Pages: 7

DOI: 10.2174/2772574X14666230808095649

Price: $65

Abstract

Objective: The ongoing pandemic of severe acute respiratory syndrome coronavirus 2019 (SARS-CoV-2) has caused an immense public health crisis worldwide. Emerging evidence has suggested that inflammatory response plays a critical role in the pathogenesis and prognosis of the disease. As vitamin D can modulate the immune system, this study has been designed to correlate vitamin D with inflammatory and prognostic markers in COVID-19 patients.

Methods: The present study is a retrospective study examining the relationship between vitamin D levels and inflammatory markers in the COVID-19 disease. COVID-19 patients who were investigated for vitamin D, ferritin, D-dimer, C-reactive protein (CRP), and procalcitonin (PCT) level were only included. The patients were divided into hypovitaminosis D, and normal vitamin D. Correlation and logistic regression analyses were carried out to identify the strength and association of hypovitaminosis D with inflammatory markers in COVID-19 disease.

Results: The hypovitaminosis D group had significantly higher inflammatory markers compared to the normal vitamin D group. The correlation between hypovitaminosis D and procalcitonin was negative (r = -0.433), with a strong and significant association (p = 0.002). The correlation between hypovitaminosis D, CRP, and ferritin was weak and insignificant. The logistic regression between hypovitaminosis D and procalcitonin established a significant regression equation, leading to a significant linear model.

Conclusion: This study concludes that patients with hypovitaminosis D should be treated with vitamin D therapy to reduce the severity of COVID-19 disease.

« Previous Next »
[1]
Li, H.; Liu, S.M.; Yu, X.H.; Tang, S.L.; Tang, C.K. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int. J. Antimicrob. Agents, 2020, 55(5), 105951.
[http://dx.doi.org/10.1016/j.ijantimicag.2020.105951] [PMID: 32234466]
[2]
Sohrabi, C.; Alsafi, Z.; O’Neill, N.; Khan, M.; Kerwan, A.; Al-Jabir, A.; Iosifidis, C.; Agha, R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int. J. Surg., 2020, 76, 71-76.
[http://dx.doi.org/10.1016/j.ijsu.2020.02.034] [PMID: 32112977]
[3]
Guan, W.; Ni, Z.; Hu, Y.; Liang, W.; Ou, C.; He, J.; Liu, L.; Shan, H.; Lei, C.; Hui, D.S.C.; Du, B.; Li, L.; Zeng, G.; Yuen, K.Y.; Chen, R.; Tang, C.; Wang, T.; Chen, P.; Xiang, J.; Li, S.; Wang, J.; Liang, Z.; Peng, Y.; Wei, L.; Liu, Y.; Hu, Y.; Peng, P.; Wang, J.; Liu, J.; Chen, Z.; Li, G.; Zheng, Z.; Qiu, S.; Luo, J.; Ye, C.; Zhu, S.; Zhong, N. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med., 2020, 382(18), 1708-1720.
[http://dx.doi.org/10.1056/NEJMoa2002032] [PMID: 32109013]
[4]
Mehta, P.; McAuley, D.F.; Brown, M.; Sanchez, E.; Tattersall, R.S.; Manson, J.J. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet, 2020, 395(10229), 1033-1034.
[http://dx.doi.org/10.1016/S0140-6736(20)30628-0] [PMID: 32192578]
[5]
Stebbing, J.; Phelan, A.; Griffin, I.; Tucker, C.; Oechsle, O.; Smith, D.; Richardson, P. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect. Dis., 2020, 20(4), 400-402.
[http://dx.doi.org/10.1016/S1473-3099(20)30132-8] [PMID: 32113509]
[6]
Tay, M.Z.; Poh, C.M.; Rénia, L.; MacAry, P.A.; Ng, L.F.P. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol., 2020, 20(6), 363-374.
[http://dx.doi.org/10.1038/s41577-020-0311-8] [PMID: 32346093]
[7]
Xu, Z.; Shi, L.; Wang, Y.; Zhang, J.; Huang, L.; Zhang, C.; Liu, S.; Zhao, P.; Liu, H.; Zhu, L.; Tai, Y.; Bai, C.; Gao, T.; Song, J.; Xia, P.; Dong, J.; Zhao, J.; Wang, F.S. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med., 2020, 8(4), 420-422.
[http://dx.doi.org/10.1016/S2213-2600(20)30076-X] [PMID: 32085846]
[8]
Chen, L.; Liu, H.G.; Liu, W.; Liu, J.; Liu, K.; Shang, J.; Deng, Y.; Wei, S. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia Zhonghua Jie He He Hu Xi Za Zhi,, 2020, 43(3), 203-208.
[PMID: 32164089]
[9]
Gao, Y.; Li, T.; Han, M.; Li, X.; Wu, D.; Xu, Y.; Zhu, Y.; Liu, Y.; Wang, X.; Wang, L. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J. Med. Virol., 2020, 92(7), 791-796.
[http://dx.doi.org/10.1002/jmv.25770] [PMID: 32181911]
[10]
Qin, C.; Zhou, L.; Hu, Z.; Zhang, S.; Yang, S.; Tao, Y. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin. Infect. Dis., 2020, 71(15), 762-768.
[11]
Cheng, L.; Li, H.; Li, L.; Liu, C.; Yan, S.; Chen, H.; Li, Y. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J. Clin. Lab. Anal., 2020, 34(10), e23618.
[http://dx.doi.org/10.1002/jcla.23618] [PMID: 33078400]
[12]
Oualim, S.; Abdeladim, S.; Elouarradi, A.; Bensahi, I.; Hafid, S.; Naitelho, A.; Bouaiti, E.; Sabry, M. Elevated levels of D-dimer in patients with COVID-19: prognosis value. Pan Afr. Med. J., 2020, 35(S2), 105.
[http://dx.doi.org/10.11604/pamj.supp.2020.35.2.24692] [PMID: 33282060]
[13]
Hu, R.; Han, C.; Pei, S.; Yin, M.; Chen, X. Procalcitonin levels in COVID-19 patients. Int. J. Antimicrob. Agents, 2020, 56(2), 106051.
[http://dx.doi.org/10.1016/j.ijantimicag.2020.106051] [PMID: 32534186]
[14]
Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; Xia, J.; Yu, T.; Zhang, X.; Zhang, L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395(10223), 507-513.
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[15]
Mo, P.; Xing, Y.; Xiao, Y. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin. Infect. Dis., 2020, 73(11), e4208-e4213.
[http://dx.doi.org/10.1093/cid/ciaa270] [PMID: 32173725]
[16]
Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Ross, A.C.; Taylor, C.L.; Yaktine, A.L., Eds.; National Academies Press: Washington, DC, 2011.
[17]
Wacker, M.; Holick, M. Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients, 2013, 5(1), 111-148.
[http://dx.doi.org/10.3390/nu5010111] [PMID: 23306192]
[18]
Holick, M.F.; Binkley, N.C.; Bischoff-Ferrari, H.A.; Gordon, C.M.; Hanley, D.A.; Heaney, R.P.; Murad, M.H.; Weaver, C.M. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab., 2011, 96(7), 1911-1930.
[http://dx.doi.org/10.1210/jc.2011-0385] [PMID: 21646368]
[19]
Cardoso, M.P.; Pereira, L.A.L. Native vitamin D in pre-dialysis chronic kidney disease. Nefrologia, 2019, 39(1), 18-28.
[http://dx.doi.org/10.1016/j.nefroe.2018.07.007] [PMID: 30274806]
[20]
Pinzon, R.T.; Angela; Pradana, A.W. Vitamin D deficiency among patients with COVID-19: case series and recent literature review. Trop. Med. Health, 2020, 48(1), 102.
[http://dx.doi.org/10.1186/s41182-020-00277-w] [PMID: 33342439]
[21]
Demir, M.; Demir, F.; Aygun, H. Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease. J. Med. Virol., 2021, 93(5), 2992-2999.
[http://dx.doi.org/10.1002/jmv.26832] [PMID: 33512007]
[22]
Jain, A.; Chaurasia, R.; Sengar, N.S.; Singh, M.; Mahor, S.; Narain, S. Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Sci. Rep., 2020, 10(1), 20191.
[http://dx.doi.org/10.1038/s41598-020-77093-z] [PMID: 33214648]
[23]
Gupta, S.K.; Aparna, P.; Muthathal, S.; Nongkynrih, B. Vitamin D deficiency in India. J. Family Med. Prim. Care, 2018, 7(2), 324-330.
[http://dx.doi.org/10.4103/jfmpc.jfmpc_78_18] [PMID: 30090772]
[24]
Thacher, T.D.; Clarke, B.L. Vitamin D insufficiency. Mayo Clin. Proc., 2011, 86(1), 50-60.
[http://dx.doi.org/10.4065/mcp.2010.0567] [PMID: 21193656]
[25]
Khan, N.; Chen, X.; Geiger, J.D. Role of endolysosomes in severe acute respiratory syndrome coronavirus-2 infection and coronavirus disease 2019 pathogenesis: implications for potential treatments. Front. Pharmacol., 2020, 11595888.
[http://dx.doi.org/10.3389/fphar.2020.595888] [PMID: 33324224]
[26]
Xiao, D.; Li, X.; Su, X.; Mu, D.; Qu, Y. Could SARS-CoV-2-induced lung injury be attenuated by vitamin D? Int. J. Infect. Dis., 2021, 102, 196-202.
[http://dx.doi.org/10.1016/j.ijid.2020.10.059] [PMID: 33129966]
[27]
Rafiullah, M. can a combination of AT1R antagonist and vitamin D treat the lung complication of COVID-19? Am. J. Med. Sci., 2020, 360(4), 338-341.
[http://dx.doi.org/10.1016/j.amjms.2020.07.018] [PMID: 32736832]
[28]
Malek Mahdavi, A. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID -19. Rev. Med. Virol., 2020, 30(5), e2119.
[http://dx.doi.org/10.1002/rmv.2119] [PMID: 32584474]
[29]
Zeng, F.; Huang, Y.; Guo, Y.; Yin, M.; Chen, X.; Xiao, L.; Deng, G. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int. J. Infect. Dis., 2020, 96, 467-474.
[http://dx.doi.org/10.1016/j.ijid.2020.05.055] [PMID: 32425643]
[30]
Ginde, A.A.; Mansbach, J.M.; Camargo, C.A., Jr Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third national health and nutrition examination survey. Arch. Intern. Med., 2009, 169(4), 384-390.
[http://dx.doi.org/10.1001/archinternmed.2008.560] [PMID: 19237723]
[31]
Martineau, A.R.; Jolliffe, D.A.; Hooper, R.L.; Greenberg, L.; Aloia, J.F.; Bergman, P.; Dubnov-Raz, G.; Esposito, S.; Ganmaa, D.; Ginde, A.A.; Goodall, E.C.; Grant, C.C.; Griffiths, C.J.; Janssens, W.; Laaksi, I.; Manaseki-Holland, S.; Mauger, D.; Murdoch, D.R.; Neale, R.; Rees, J.R.; Simpson, S., Jr; Stelmach, I.; Kumar, G.T.; Urashima, M.; Camargo, C.A., Jr Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ, 2017, 356, i6583.
[http://dx.doi.org/10.1136/bmj.i6583] [PMID: 28202713]
[32]
Tsujino, I.; Ushikoshi-Nakayama, R.; Yamazaki, T.; Matsumoto, N.; Saito, I. Pulmonary activation of vitamin D3 and preventive effect against interstitial pneumonia. J. Clin. Biochem. Nutr., 2019, 65(3), 245-251.
[http://dx.doi.org/10.3164/jcbn.19-48] [PMID: 31777427]
[33]
Khoo, A.L.; Chai, L.; Koenen, H.; Joosten, I.; Netea, M.; van der Ven, A. Translating the role of vitamin D 3 in infectious diseases. Crit. Rev. Microbiol., 2012, 38(2), 122-135.
[http://dx.doi.org/10.3109/1040841X.2011.622716] [PMID: 22304022]
[34]
Cantorna, M.T.; Zhu, Y.; Froicu, M.; Wittke, A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am. J. Clin. Nutr., 2004, 80(6)(Suppl.), 1717S-1720S.
[http://dx.doi.org/10.1093/ajcn/80.6.1717S]
[35]
Mahon, B.D.; Wittke, A.; Weaver, V.; Cantorna, M.T. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J. Cell. Biochem., 2003, 89(5), 922-932.
[http://dx.doi.org/10.1002/jcb.10580] [PMID: 12874827]
[36]
Maillard, C.; Berruyer, M.; Serre, C.M.; Amiral, J.; Dechavanne, M.; Delmas, P.D. Thrombomodulin is synthesized by osteoblasts, stimulated by 1,25-(OH)2D3 and activates protein C at their cell membrane. Endocrinology, 1993, 133(2), 668-674.
[http://dx.doi.org/10.1210/endo.133.2.8393772] [PMID: 8393772]
[37]
Koyama, T.; Shibakura, M.; Ohsawa, M.; Kamiyama, R.; Hirosawa, S. Anticoagulant effects of 1alpha,25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes. Blood, 1998, 92(1), 160-167.
[http://dx.doi.org/10.1182/blood.V92.1.160.413k16_160_167] [PMID: 9639512]
[38]
Ohsawa, M.; Koyama, T.; Yamamoto, K.; Hirosawa, S.; Kamei, S.; Kamiyama, R. 1alpha,25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation, 2000, 102(23), 2867-2872.
[http://dx.doi.org/10.1161/01.CIR.102.23.2867] [PMID: 11104746]
[39]
Holick, M.F. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr. Opin. Endocrinol. Diabetes, 2002, 9(1), 87-98.
[http://dx.doi.org/10.1097/00060793-200202000-00011]
[40]
Hewison, M.; Zehnder, D.; Chakraverty, R.; Adams, J.S. Vitamin D and barrier function: a novel role for extra-renal 1α--hydroxylase. Mol. Cell. Endocrinol., 2004, 215(1-2), 31-38.
[http://dx.doi.org/10.1016/j.mce.2003.11.017] [PMID: 15026172]
[41]
Jain, Analysis of vitamin D level among asymptomatic and critically ill COVID 19 patients and its correlation with infammatory markers. Nature research. 2020, 10, 2019.
[42]
Lippi, G.; Plebani, M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Clin. Chim. Acta, 2020, 505, 190-191.
[http://dx.doi.org/10.1016/j.cca.2020.03.004] [PMID: 32145275]
[43]
Carpagnano, G.E.; Di Lecce, V.; Quaranta, V.N.; Zito, A.; Buonamico, E.; Capozza, E.; Palumbo, A.; Di Gioia, G.; Valerio, V.N.; Resta, O. Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J. Endocrinol. Invest., 2021, 44(4), 765-771.
[http://dx.doi.org/10.1007/s40618-020-01370-x] [PMID: 32772324]
[44]
A Lakkireddy, m.; Gadiga,, SG.; Malathi, RD. Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease. Sci. Rep., 2021, 11(1), 10641.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy